Right Phrenic Nerve Localization on CT for Ablation
1 other identifier
observational
80
1 country
1
Brief Summary
The anatomical location of the right phrenic nerve (RPN) in close proximity to the right pulmonary veins has become a critical consideration for electrophysiologists performing pulmonary vein isolation, the cornerstone treatment for atrial fibrillation. Although radiofrequency ablation in this region is rarely associated with complications-unlike cryoballoon ablation-the proximity of the RPN to the ablation site is considered the most widely accepted mechanism of nerve injury. Therefore, accurately defining its anatomical course is essential to prevent complications. This concern extends to any ablation procedure performed near the RPN, including those targeting the lateral-posterior region of the right atrium, particularly during atrial tachycardia ablation or cardioneuroablation. Several methods have been used to precisely localize the RPN. The most commonly employed technique is phrenic nerve stimulation; however, there is growing interest in the use of computed tomography (CT) to identify structures running parallel to the nerve-such as the pericardiophrenic artery and vein-enhanced with contrast. Three-dimensional reconstruction through image segmentation has proven useful in defining the anatomy of cardiac chambers and adjacent extracardiac structures. This study aims to compare two approaches for visualizing the course of the right phrenic nerve: one based on computed tomography imaging and the other on the nerve's response to stimulation during the procedure. This comparison will allow us to assess the concordance between imaging findings and intra-procedural observations, ultimately contributing to improved procedural safety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 29, 2025
CompletedFirst Submitted
Initial submission to the registry
December 10, 2025
CompletedFirst Posted
Study publicly available on registry
January 9, 2026
CompletedJanuary 9, 2026
September 1, 2025
6 months
December 10, 2025
January 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
analyse the anatomy of the RPN
The primary endpoint of this study is to analyse the anatomy of the RPN using three-dimensional (3D) imaging and iso-distance mapping with ADAS® software, and to validate its accuracy through traditional pace mapping.
From January 2021 to April 2025
Accuracy of Imaging-Guided Anatomical Localization of the Phrenic Nerve with ADAS® software Compared With Conventional Pacemapping
The positions as observed by the 2 different methods are compared and the correlation was expressed as a percentage. Global image correlation is computed as the mean correlation between methods.
from the procedure to 12 months later
Study Arms (1)
This study will enroll patients undergoing two distinct types of ablative procedures g
A total of 80 consecutive patients will be included: * 60 patients will be enrolled using a single electric stimulation output set at 20 mA, 2 ms amplitude width and 1000 ms cycle length * 20 patients will be enrolled using a double electric stimulation output set respectively at 10 mA and 20 mA (2 ms amplitude width and 1000 ms cycle length)
Eligibility Criteria
All patients underwent an electrocardiography-gated cardiovascular CT using a 64-slice multidetector row CT scanner (Revolution CT, GE Healthcare Global Diagnostic Imaging) prior to the ablation procedure. The position line was set at 0.5 cm below the tracheal bifurcation to the cardiac diaphragmatic surface. The acquisition was performed within a single breath- hold. The gantry rotation time was 0.35 s, and the tube current was 350-750 mA at 120 kV. Iodinated contrast material (60 mL; Omnipaque 300 mg/mL), was injected at a rate of 4-5 mL/s, followed by 20 mL of saline solution. A second acquisition immediately after is performed to study the venous phase. Original images at 75% or 45% R-R intervals were transferred to post-processing Workstation, with a section thickness of 0.625 mm. If motion artifacts appeared, the electrocardiographic editing technique was used and the reconstructed window was moved forward or backward for 5% R-R interval until the motion artifacts disappeared.
You may qualify if:
- Ability to provide informed consent
- Patients who have undergone or will undergo transcatheter AF ablation or CNA
- Availability of 64-slice contrast-enhanced MDCT with RPN segmentation using ADAS® software prior to ablation
- Age ≥ 18 years
You may not qualify if:
- Inability to provide informed consent
- Inability to perform contrast-enhanced CT before transcatheter AF ablation or CNA
- Age \< 18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Antonio Berruezo
Barcelona, Barcelona, 08022, Spain
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of Electrophysiology Unit
Study Record Dates
First Submitted
December 10, 2025
First Posted
January 9, 2026
Study Start
April 1, 2025
Primary Completion
September 20, 2025
Study Completion
September 29, 2025
Last Updated
January 9, 2026
Record last verified: 2025-09